"Dr. Sarah Abdellatif was born and raised in Spring, Texas, and attended Klein High School, graduating third in her class. She attended UT Austin and majored in biology. She received her medical degree from the Texas College of Osteopathic Medicine/UNT Health Science Center and completed a family medicine residency at the University of Wyoming in Casper. During medical school, Dr. Abdellatif developed a passion for sports medicine and went on to complete a sports medicine fellowship at the UT Health Science Center in Houston."

During the past decade, St Lukes Medical Group conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St Lukes Medical Group" #1 sponsor was "Glaxo Wellcome" with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Pharmacia and Upjohn" with 2 trials sponsored, "St. Luke's Health System, Boise, Idaho" with 2 trials sponsored and "Chiron Corporation" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St Lukes Medical Group" #1 collaborator was "Idaho Suicide Prevention Hotline (Jannus, Inc.)" with 2 trials as a collaborator, "Patient-Centered Outcomes Research Institute" with 2 trials as a collaborator, "University of Washington" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Columbia University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "St Lukes Medical Group" are "HIV Infections" (7 trials), "Mental Health" (2 trials), "Migraine" (2 trials), "Adolescent" (1 trials) and "Adult" (1 trials). Many other conditions were trialed in "St Lukes Medical Group" in a lesser frequency.

Most popular intervention types in "St Lukes Medical Group" are "Drug" (10 trials), "Other" (3 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abacavir sulfate" (3 trials), "Didanosine" (3 trials), "Delavirdine mesylate" (2 trials), "Efavirenz" (2 trials) and "Lamivudine" (2 trials). Other intervention names were less common.

The vast majority of trials in "St Lukes Medical Group" are 14 trials for "All" genders.

Currently, there are NaN active trials in "St Lukes Medical Group". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in St Lukes Medical Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in St Lukes Medical Group, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".